Newsroom 2010

Press release: PAION starts Phase IIb study with its short-acting anaesthetic/sedative CNS 7056 in patients undergoing colonoscopy

Download (25 KB)

Press release: PAION AG reports results for the first quarter 2010

Download (46KB)

Press release: PAION AG enters into an equity facility agreement for EUR 15 million

Download (32 KB)

Ad hoc: PAION AG enters into an equity facility agreement for EUR 15 million

Download (23 KB)

Press release: Start of Japanese Phase I with CNS 7056 triggered first milestone of one million USD for PAION from Ono Pharmaceutical

Download (26 KB)

Press release: PAION reaches agreement with FDA on Phase IIb study design for its short-acting anaesthetic/sedative CNS 7056 in patients undergoing colonoscopy

Download (27 KB)

Press release: Filing of IND application for GGF2 in heart failure by PAION’s partner Acorda Therapeutics triggers first milestone payments

Download (25 KB)

Press release: PAION’s partner Lundbeck initiates Japanese Clinical Phase II Trial with Desmoteplase in ischaemic stroke

Download (32 KB)

Press release: PAION AG reports results for the fiscal year 2009

Download (46 KB)

Press release: PAION’s Partner Lundbeck Presented Data From a post-hoc Analysis Using Desmoteplase in Ischaemic Stroke

Download (25 KB)

For further information: Press release on Lundbeck's web site

Press release: PAION announces initiation of clinical development activities with short-acting anaesthetic/sedative CNS 7056 (ONO’s Development code: ONO-2745) by its Partner ONO Pharmaceutical in Japan

Download (24 KB)